$85.88 $1.99 (2.4%)

04:23 PM EDT on 05/29/20

EXACT Sciences Corp (NASDAQ:EXAS)

CAPS Rating: 4 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Current Price $85.88 Mkt Cap $12.9B
Open $84.00 P/E Ratio 0.00
Prev. Close $85.88 Div. (Yield) $0.00 (0.0%)
Daily Range $82.06 - $86.00 Volume 1,294,234
52-Wk Range $35.25 - $123.99 Avg. Daily Vol. 1,675,618

Caps

How do you think NASDAQ:EXAS will perform against the market?

Add Stock to CAPS Watchlist

All Players

272 Outperform
33 Underperform
 

All-Star Players

61 Outperform
8 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EXAS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (58.83)
Submitted January 31, 2020

They say that there are no atheists in foxholes. You know what I think? I think that all of those Cologuard atheists out there are going to be reborn when it comes time for their first colonoscopy. They'll be singing the praises of Cologuard while… More

zzlangerhans (99.41)
Submitted June 26, 2016

Exact stock does well when something happens to fuel speculation about the long-term profitability of Cologuard, and badly when actual quarterly revenues and losses are released. That reminds me of another stock that has a large cult following and… More

NASDAQ:EXAS VS S&P 500 (SPY)

Fools bullish on NASDAQ:EXAS are also bullish on:

Fools bearish on NASDAQ:EXAS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EXAS.

Recs

0
Member Avatar NHWeston102 (78.03) Submitted: 4/1/2020 1:54:04 PM : Outperform Start Price: $53.90 NASDAQ:EXAS Score: +36.22

You ever had a colonoscopy!!?? If Cologuard can make this procedure extinct, EXAS will make a fortune. They are also doing promising work on Liver and Kidney diagnostics.

Recs

1
Member Avatar odocoileus (58.83) Submitted: 1/30/2020 10:32:09 PM : Outperform Start Price: $27.50 NASDAQ:EXAS Score: +164.46

They say that there are no atheists in foxholes. You know what I think? I think that all of those Cologuard atheists out there are going to be reborn when it comes time for their first colonoscopy. They'll be singing the praises of Cologuard while sitting on the porcelain throne. No nasty prep, no time off work, no invasive instruments going in through the out door. Good accuracy, good specificity. The small percentage you give up in detection is made up for in frequency (every three years for Cologuard vs. every 10 years for colonoscopy). Trust me or do the math. It's not for you high risk folks out there, but the average-risk market is huge. Covered by almost all insurance and competition is years away. They are using the same tech to develop blood assays for other cancers (liver is the furthest along, but they have a lot of irons in the fire). I actually bought this in real life in 2009 way before I green thumbed it, and it truly has been the gift that keeps on giving. Though I've sold some shares, I've rarely ever felt that this stock will do anything but go up in the long term.

Recs

0
Member Avatar freecapital (79.59) Submitted: 12/28/2019 12:10:26 AM : Outperform Start Price: $96.06 NASDAQ:EXAS Score: -5.09

Frazis

Leaderboard

Find the members with the highest scoring picks in EXAS.

Score Leader

jpmj

jpmj (66.58) Score: +3,043.64

The Score Leader is the player with the highest score across all their picks in EXAS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
proisback 69.84 9/24/2009 Outperform 3M $2.88 +2,877.95% +186.41% +2,691.54 1 Comment
theonlypro4U < 20 9/23/2009 Outperform 3M $2.89 +2,867.65% +183.30% +2,684.35 1 Comment
chas1232123 < 20 9/23/2009 Outperform 3Y $2.91 +2,847.35% +184.73% +2,662.63 1 Comment
coolyo514 88.59 12/17/2009 Outperform 5Y $2.94 +2,819.06% +175.76% +2,643.30 0 Comment
DUTCHMAN67 63.04 12/17/2009 2/16/2012 Outperform 5Y $2.96 +2,798.45% +176.31% +2,622.14 0 Comment
JavaChipFool 73.94 12/22/2009 Outperform 5Y $2.97 +2,787.61% +172.55% +2,615.06 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. pantastic 79.59 12/17/2009 Outperform 5Y $2.98 +2,778.12% +176.14% +2,601.98 0 Comment
NickJ100 79.50 12/17/2009 9/24/2014 Outperform 1Y $3.01 +2,749.34% +175.56% +2,573.77 0 Comment
fiberoptical 64.60 12/18/2009 Outperform 3M $3.06 +2,702.78% +176.56% +2,526.22 0 Comment
ecoeddy 49.91 12/18/2009 Outperform 5Y $3.06 +2,702.78% +176.56% +2,526.22 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EXAS.